Clinical and sociodemographic characterization Diabetes Mellitus in pediatric patients of the Hospital Regional de la Orinoquía, Yopal, Colombia
DOI:
https://doi.org/10.22517/25395203.25127Keywords:
Keywords: Diabetes mellitus type 2, Symptomatology, Complications, Associated diseases, Glycemia, Incidence.Abstract
Introduction: Diabetes mellitus (DM) is a chronic metabolic disorder that is increasing in the pediatric population and leads to multiple micro and macrovascular complications. It is a public health problem due to the high costs of diagnosis and treatment. According to the International Diabetes Federation (IFD) the annual incidence in the world is increasing, due to an age prevalence between 0-14 years of 98.2% and 0-19 years of 128.9% between 2019 and 2021 with an incidence of 108.3% and 149.5% respectively per 100,000 inhabitants in 215 countries.
Objective: To describe the clinical characteristics of a group of children and adolescents admitted to the emergency department of the Hospital Regional de la Orinoquía (HORO) in Yopal-Casanare in the period 2019 to 2020 with de novo or previous diagnosis of diabetes mellitus.
Methodology: An observational, descriptive, and retrospective study, case series type, where patients under 18 years of age with de novo or previous diagnosis of diabetes mellitus in the period of 2019 -2020 in the Regional Hospital of Orinoquía were included. A total of 15 patients were analyzed.
Results: The classification of the patients according to age group and sex shows a predominance of the male gender with 53.3% of the 15 patients who met the diagnostic criteria, while the female population was 46.6%. The average age of the pediatric patients was 13 ± 13.2
Conclusions: The study carried out at the Hospital Regional de la Orinoquía showed that the most frequent age group was 11 to 13 years old, with a significant predominance of males, coming from urban areas. It was found that low weight is an alarming fact n addition to altered glycemia values that are related to the complications presented at the time of admission of the patient, which represents a public health problem among children and young adults due to the heterogeneity of the genetic and environmental factors.
Downloads
References
Fornari E, Barbetti F, Iafusco D, Lombardo F, Miraglia Dal Giudice E, Rabbone I, et al. Diabe- tes tipo 2 en pediatría. Minerva Pediatr (Torino). 2021;73(6):549–62. Disponible en: http:// dx.doi.org/10.23736/S2724-5276.21.06530-7
Alustiza E, Perales A, Mateo-Abad M, Ozcoidi I, Aizpuru G, Albaina O, et al. Tackling risk factors for type 2 diabetes in adolescents: PRE-STARt study in Euskadi. An Pediatr (Barc). 2021 [cited 2022 Feb 5];95(3):186–96. Available from:https://www.analesdepediatria. org/es-abordaje-factores-riesgo-diabetes-tipo-articulo-S169540332030480X
Lawrence JM, Divers J, Isom S, Saydah S, Imperatore G, Pihoker C, et al. Tendencias en la prevalencia de diabetes tipo 1 y tipo 2 en niños y adolescentes en los EE. UU., 2001-2017. JAMA. 2021;326(8):717–27. Disponible en: https://jamanetwork.com/journals/jama/ful- larticle/2783420
Ogle GD, James S, Dabelea D, Pihoker C, Svennson J, Maniam J, et al. Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas, 10th edition.Diabetes Res Clin Pract. 2022 [cited 2022 Feb 11];183(109083):109083. Available from: https://www.diabetesresearchclinicalpractice. com/article/S0168-8227(21)00442-3/fulltext
Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers. 2017 [cited 2022 Feb 10];3(1):17016. Avail- able from: https://www.nature.com/articles/nrdp201716DiMeglio LA, Evans-Molina C,
Oram RA. Type 1 diabetes. Lancet [Internet]. 2018 [cited 2022 Feb 10];391(10138):2449– 62. Available from: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC6661119/
Valaiyapathi B, Gower B, Ashraf AP. Pathophysiology of type 2 diabetes in children and adolescents. Curr Diabetes Rev. 2020 [cited 2022 Feb 10];16(3):220–9. Available from: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7516333/?report=reader
Castro-Juárez CJ, Ramírez-García SA, Villa-Ruano N, García-Cruz D. Epidemiología gené- tica sobre teorías causales y patogenia de la diabetes mellitus tipo 2. Gac Med Mex. 2019 [citado el 5 de febrero de 2022];153(7). Disponible en: https://www.gacetamedicademex- ico.com/frame_eng.php?id=87
Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Rev [Internet]. 2020 [cited 2022 Feb 10];16(5):442–9. Available from: https://pubmed.ncbi.nlm.nih.gov/31657690/
Ros P, Barrio R. Diabetes tipo 2 en la infancia y adolescencia. An Pediatr Contin. 2009 [cited 2022 Feb 5];7(3):127–35. Available from: https://www.elsevier.es/es-revista-anales-pedia- tria-continuada-51-articulo-diabetes-tipo-2-infancia-adolescencia-S1696281809711163
Ros P, Barrio R. Diabetes tipo 2 en la infancia y adolescencia. An Pediatr Contin [Inter- net]. 2009 [cited 2022 Feb 5];7(3):127–35. Available from: https://www.elsevier.es/ es-revista-anales-pediatria-continuada-51-articulo-diabetes-tipo-2-infancia-adolescen- cia-S1696281809711163
Koren D, Levitsky LL. Type 2 diabetes mellitus in childhood and adolescence. Pediatr Rev. 2021[cited2022Feb5];42(4):16779.Availablefrom:https://publications.aap.org/pediatric- sinreview/article-abstract/42/4/167/180698/Type-2-Diabetes-Mellitus-in-Childhood- and?redirectedFrom=fulltext
Hamilton H, Knudsen G, Vaina CL, Smith M, Paul SP. Children and young people with dia- betes: recognition and management. Br J Nurs. 2017;26(6):340–7. Available from: http:// dx.doi.org/10.12968/bjon.2017.26.6.340
Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P. Evaluation and manage- ment of youth-onset type 2 diabetes: A position statement by the American diabetes asso- ciation. Diabetes Care. 2018 [citado el 7 de febrero de 2022];41(12):2648–68. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30425094/
Serbis A, Giapros V, Kotanidou EP, Galli-Tsinopoulou A, Siomou E. Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents. World J Diabetes. 2021 [citado el 7 de febrero de 2022];12(4):344–65. Disponible en: https://www.ncbi.nlm.nih. gov/labs/pmc/articles/PMC8040084/
Graves LE, Donaghue KC. Vascular complication in adolescents with diabetes mellitus. Front Endocrinol (Lausanne). 2020 [cited 2022 Feb 5];11:370. Available from: https:// www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7295945/
Mayer-Davis EJ, Kahkoska AR, Jefferies C, Dabelea D, Balde N, Gong CX, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018;19 Suppl 27:7-19. Dis- ponible en: http://dx.doi.org/10.1111/pedi.12773
Downloads
-
Vistas(Views): 363
- PDF (Español (España)) Descargas(Downloads): 160
Published
Versions
- 2023-08-02 (3)
- 2023-07-13 (2)
- 2023-06-29 (1)
How to Cite
Issue
Section
License
Cesión de derechos y tratamiento de datos
La aceptación de un artículo para su publicación en la Revista Médica de Risaralda implica la cesión de los derechos de impresión y reproducción, por cualquier forma y medio, del autor a favor de Facultad de Ciencias de la Salud de la Universidad Tecnológica de Pereira. 1995-2018. Todos los derechos reservados ®
por parte de los autores para obtener el permiso de reproducción de sus contribuciones. La reproducción total o parcial de los trabajos aparecidos en la Revista Médica de Risaralda, debe hacerse citando la procedencia, en caso contrario, se viola los derechos reservados.
Asimismo, se entiende que los conceptos y opiniones expresados en cada trabajo son de la exclusiva responsabilidad del autor, sin responsabilizarse ni solidarizarse, necesariamente, ni la redacción, ni la editorial.
Es responsabilidad de los autores poder proporcionar a los lectores interesados copias de los datos en bruto, manuales de procedimiento, puntuaciones y, en general, material experimental relevante.
Asimismo, la Dirección de la revista garantiza el adecuado tratamiento de los datos de carácter personal